In vitro evaluation of Terminalia arjuna on calcium phosphate and calcium oxalate crystallization

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 3, 2010, Pages 340-345

  Chaudhary, A ^a   Singla, S K ^b   Tandon, C ^a  

^a JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

calcium oxalate; Calcium phosphate; saponin; Terminalia arjuna; TLC; urolithiasis

Indexed keywords

ANTIUROLITHIASIS AGENT; BUTANOL; CALCIUM OXALATE; CALCIUM PHOSPHATE; SOLVENT; TERMINALIA ARJUNA EXTRACT; WHEWELLITE;

ARTICLE; CONTROLLED STUDY; CRYSTAL; CRYSTALLIZATION; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; DRUG SCREENING; IN VITRO STUDY; TERMINALIA; TERMINALIA ARJUNA;

EID: 77957748316     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.70480     Document Type: Article

References (26)

1. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. New Engl J Med 1992;327:1141-52.
2. Beghalia M, Ghalem S, Hocine AH, Belouatek A, Marouf A. Effect of herbal extracts of Tetraclinis articulate and Chamaerops humilis on calcium oxalate crystals in vitro. Gomal J Med Sci 2007;5:55-8.
3. Joseph KC, Bharat B, Parekh, Joshi MJ. Inhibition of growth of urinary type calcium hydrogen phosphate dihydrate crystals by tartaric acid and tamarind. Curr Sci 2005;88:1232-8.
4. Pak C Y, Poindexter JR, Adams-Huet B, Pearle MS. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003;115:26-32.
5. Terlecki RP, Triest JA. A contemporary evaluation of the auditory hazard of extracorporeal shock wave lithotripsy. Urology 2007;70:898-9.
6. Prasad K V S R G, Sujatha D, Bharathi K. Herbal Drugs in Urolithiasis-A Review. Phcog Rev 2007;1:175-9.
7. Beghalia M, Ghalem S, Allali H, Belouatek A, Marouf A. Inhibition of calcium oxalate monohydrate crystal growth using Algerian medicinal plants. J Med Plant 2008;2:66-70.
8. Cheng HY, Lin CC, Lin TC. Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna. Antiviral Res 2002;55:447-55.
9. Nagpal A, Meena LS, Kaur S, Grover IS, Wadhwa R, Kaul SC. Growth of suppression of human transformed cells by treatment with bark extracts from a medicinal plant Terminalia arjuna in-vitro cell. Dev Biol Anim 2000;36:544.
10. Chander R, Singh K, Khanna AK, Kaul SM, Puri A, Saxena R, et al. Antidyslipiddemic and antioxidant activities of different fraction of Terminalia arjuna bark. Indian J Clin Biochem 2004;19:141-8.
11. Manna P, Sinha M, Parames CS. Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Complementary and Alternative Medicine 2006;6:33
12. Kabra SG, Kabra V, Banerji P, Jain LK, Bhargava A, Chaturvedi RP. In vitro calculogenesis: Methods to develop concretions of desired chemical composition. Indian J Exp Biol 1978;16:212-7.
13. Singla S, Jethi RK. A simple method for the study of in vitro calculogenesis. Indian J Exp Biol 1981;19:283-5.
14. Trinder P. Colorimetric microdetermination of calcium in serum. Analyst 1960;85:889-94.
15. Gomori HD. A modification of colorimetric phosphorous determination for use with photoelectric colorimeter. J Lab Clin Med 1941;27:955-60.
16. Porlie JL, Asplin JR, Parks JH, Y. Nakagawa, Coe FL. Normal Calcium Oxalate Crystal Growth Inhibition in Severe Calcium Oxalate Nephrolithiasis. J Am Soc Nephrol 1996;7:602-7.
17. Asghar MN, Khan IU, Zia I, Ahmad M, Qureshi FA. Modified 2, 2'-Azinobis (3-Ethylbenzo Thiazoline)-6-Sulphonic Acid Radical Cation Decolorization Assay for Antioxidant Activity of Human Plasma and Extracts of Traditional Medicinal Plants. Acta Chim Slov 2008;55:408-18.
18. Egwaikhide PA, Gimba CE. Analysis of the Phytochemical Content and Anti-microbial Activity of Plectranthus glandulosis Whole Plant. Middle-East J Sci Res 2007;2:135-8.
19. Matan G, Ayelet A, Mutaz Q, Hassan D, Saleh AL, Ulfert F, et al. Quillaja saponins inhibit tilapia aromatase activity in vitro. Cybium 2008;32:80-2.
20. Konigsberger E, Konigsberger LC. Thermodynamic modeling of crystal deposition in humans. Pure Appl Chem 2001;73:785-97.
21. Aggarwal S, Tandon C, Forouzandeh M, Singla SK, Kiran R, Jethi RK. Role of a protein inhibitor isolated from human renal stone matrix in urolithiasis. Indian J Biochem Biophys 2005;42:113-7.
22. Bushinsky DA, Walter R P, John RA. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 2000;57:550-60.
23. Chaudhary A, Tandon C, Singla SK. Calcium oxalate crystal growth inhibition by aqueous extract of Tamarindus indica. Indian J Urol 2008;24: S-111.
24. Kaur T, Bijarnia RK, Singla SK, Tandon C. Purification and characterization of an anticalcifying protein from the seeds of Trachyspermum ammi (L.). Protein Pept Lett 2009;16:173-81.
25. Fouada A, Yamina S, Nait MA, Mohammed B, Abdlekrim R. In vitro and in vivo Antilithiasic Effect of Saponin Rich Fraction Isolated From Herniaria hirsute. J Bras Nefrol 2006;28:199-203.
26. Chen CH, Liu TZ, Kuo TC, Lu FJ, Chen YC, Chang-Chien YW, et al. Casuarinin protects cultured MDCK cells from hydrogen peroxideinduced oxidative stress and DNA oxidative damage. Planta Med 2004;70:1022-26.